Associations between Depressive Symptomatology and Neurocognitive Impairment in HIV/AIDS.
Ontology highlight
ABSTRACT: OBJECTIVE:Mood disorders and neurocognitive impairments are debilitating conditions among patients with HIV/AIDS. How these comorbidities interact and their relationships to systemic factors remain uncertain. Herein, we investigated factors contributing to depressive symptomatology (DS) in a prospective cohort of patients with HIV/AIDS in active care that included neuropsychological assessment. METHODS:Among patients with HIV/AIDS receiving combination antiretroviral therapy (cART) and ongoing clinical assessments including measures of sleep, health-related quality of life (HQoL), neuropsychological testing, and mood evaluation (Patient Health Questionnaire-9 [PHQ-9]) were performed. Univariate and multivariate analyses were applied to the data. RESULTS:In 265 persons, 3 categories of DS w
SUBMITTER: Tymchuk S
PROVIDER: S-EPMC5912296 | biostudies-literature | 2018 May
REPOSITORIES: biostudies-literature
ACCESS DATA